PNPLA3 and metabolic dysfunction-associated steatohepatitis: One of the major findings is that the PNPLA3 I148M variant increases susceptibility to the whole spectrum of liver damage related to NAFLD, from steatosis to NASH, fibrosis, and HCC (42).